Trial Profile
Phase I single ascending dose study of T-4288 in healthy adult subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Oct 2018
Price :
$35
*
At a glance
- Drugs Solithromycin (Primary)
- Indications Bronchitis; Chlamydial infections; Chronic obstructive pulmonary disease; Community-acquired pneumonia; Gonorrhoea; Non-alcoholic steatohepatitis; Otorhinolaryngological infections; Respiratory tract infections; Sinusitis; Urethritis
- Focus Adverse reactions; First in man; Pharmacokinetics
- Sponsors Toyama Chemical
- 21 Apr 2010 New trial record.